1 asset in Canavan Disease
Therapeutic assets addressing Canavan Disease, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
aav9 bbp-812 Canavan Disease | Aspa Therapeutics | P1/2 | CCC (48) |
Therapeutic assets addressing Canavan Disease, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
aav9 bbp-812 Canavan Disease | Aspa Therapeutics | P1/2 | CCC (48) |